Revised MRPs of 1,364 anti-cancer formulations come into effect; consumers to save ₹3,540 crore/year
The Hindu

Revised maximum retail prices for 1,364 anti-cancer formulations have come into effect, expected to save consumers ₹3,540 crore annually.
According to the Ministry, 85 pharmaceutical companies have reported revised maximum retail prices for 1,364 anti-cancer formulations. These formulations span across 121 drugs as of November 8, 2026. The price revisions are projected to save consumers ₹3,540 crore per year.
Why it matters: The price reductions on anti-cancer drugs will alleviate financial burdens on patients by saving consumers ₹3,540 crore annually.





